Seven guidelines exclusively deal
with early breast cancer, four further guidelines with advanced breast cancer (stage IV).
But I think when there are red flags —
like early breast cancer, multiple breast cancers, ovarian cancer or male breast cancer — all of those families should be offered genetic testing.
Our team was the first to report that a single CTC detected in the blood of
early breast cancer patients was associated with a higher risk of metastatic relapse (Pierga, Clin Cancer Res 2008).
Up to half
of early breast cancers contain little clusters of microcalcifications, tiny deposits of calcium that on a mammogram look like a constellation of faint stars.
Promising animal studies of this method of delivering anticancer drugs, known as intraductal chemotherapy, has led to Phase I clinical trials in women with
very early breast cancer.
The researchers analysed the radiotherapy treatment plans of 1145 patients with
early breast cancer who had previously had breast - conserving surgery.
«Our results suggest that avoiding such hormone therapy may help improve the sensitivity of mammograms for
detecting early breast cancers at a stage when they are most treatable.»
PALLAS: Palbociclib Collaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR +) / Human Epidermal Growth Factor Receptor 2 (HER2)- Negative Early Breast Cancer
My translational research has focused on trying to find better ways to estimate recurrence risk in patients diagnosed with oestrogen - receptor
positive early breast cancer, with the ultimate aim to better personalise our therapies for those patients who have the most to gain from them.
Though there is still disagreement, a new study presented at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco suggests that annual mammography and palpation of breast masses remain critical tools in
early breast cancer diagnosis.
Patients can be diagnosed with metastatic disease at the time of their breast cancer diagnosis or after a period of time has elapsed since their
initial early breast cancer was treated.
A comprehensive, collaborative research project is looking for protein biomarkers that can be used for
early breast cancer detection with blood tests.
In 2014, researchers at the National Cancer Conference made the following statement: «Long term significant scalp alopecia (here lasting for up to 3.5 years following completion of chemotherapy) may affect 10 - 15 % of patients following docetaxel for EBC
[early breast cancer].
Naaman, S., & Johnson, S. M., & Radwan, K. (in review) Evaluation of the clinical efficacy of emotionally focused therapy on psychological adjustment of couples
facing early breast cancer.
But if a woman has a BRCA1 mutation and most of her relatives have developed
very early breast cancer, I worry about her a little bit more than a woman in a family with a BRCA1 mutation where, for whatever reason, they don't seem to have as many cancers.
They found that using mammography about 260 survivors of childhood lymphoma would need to be invited to have
early breast cancer screening to prevent one breast cancer death, which compares favorably to widely endorsed screening programs for average risk women aged 50 or older, which generally require 300 - 1,300 women to be invited to prevent one breast cancer death.
Barriers to obtaining gene expression profiling tests heightened their perceived importance among patients with
early breast cancer who were deciding whether to have chemotherapy, a new study says.
So Heimann and her colleagues have spent years looking for better «biomarkers,» proteins found at varying levels
in early breast cancers, which can provide clues about whether the cancer is likely to have spread.
The Telegraph reports that it is exactly the same with regards to unnecessary mastectomies: «Half of women have needless operations
for early breast cancer!»
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with
early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO).
«
Some early breast cancer patients benefit more from breast conservation than from mastectomy.»
Another 40 percent of
early breast cancers will appear on a mammogram as a mass.
Most women diagnosed with
early breast cancer can be treated successfully thanks to modern therapies including anti-oestrogen drugs.
Yet despite killing 40,000 women and men every year — a number that has not budged in decades despite gains in detection and treatment of
early breast cancers — MBC shares something in common with the much rarer angiosarcoma: Medical researchers know surprisingly little about it.
January 14, 2000 Protein predicts prognosis for breast cancer patients Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which patients with
early breast cancer will need chemotherapy following surgery.
Low levels of a protein that helps link cells together appears to be the single most effective factor for predicting which patients with
early breast cancer will need chemotherapy following surgery, report researchers from the University of Chicago Medical Center in the January 15, 2000 issue of Cancer Research.
Summary: Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which patients with
early breast cancer will need chemotherapy following surgery.
Background In our institute, the first research program on disseminated tumor cells (DTC) detection in the bone marrow of
early breast cancer patients was initiated in the late 90's; with about a thousand patients included, we constituted one of the largest cohort ever reported and contributed to the landmark report that established bone marrow DTC as a level - of - evidence 1 prognostic factor in early breast cancer (Braun, N Engl J Med 2005).
Clearly,
the earlier a breast cancer is diagnosed, the less treatment that will be required.
SATURDAY, May 31 (HealthDay News)-- A drug used to treat osteoporosis lowered the risk of breast cancer recurrence in premenopausal women with
early breast cancer.